Stay updated on Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.

Latest updates to the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page
- ChecktodayChange DetectedNew entry Revision: v3.3.4 was added and Revision: v3.3.3 was removed from the Record History. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe record history now includes a new revision entry, Revision: v3.3.3, while the HHS Vulnerability Disclosure and the prior Revision: v3.3.2 entry were removed.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page shows a new revision tag, v3.3.2, replacing the previous v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page history shows a new revision v3.3.1 added and v3.2.0 removed; changes are limited to page version metadata and do not affect study data or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedRemoved the banner notice about lapse in government funding and NIH operating status on the page. This change does not affect study data or page functionality.SummaryDifference0.6%

- Check72 days agoChange DetectedThe latest version adds updates to the study status and recruitment status in the record history, reflecting changes in the trial's progression. There are no evident additions of new documents or locations in the latest update.SummaryDifference0.1%

Stay in the know with updates to Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.